Epsilon Healthcare Limited(DE:9TH0)
€0.010.00 (0.00%)
DE:9TH0
Epsilon Healthcare Limited financials statements
€0.01
At close:0.00 (0.00%)
Epsilon Healthcare Limited (9TH0) Ratios
0 Followers
Epsilon Healthcare Limited Ratios
DE:9TH0's free cash flow for Q2 2026 was AU$802.11K. For the 2026 fiscal year, DE:9TH0's free cash flow was decreased by AU$-227.04K and operating cash flow was AU$1.03M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Jun 25 | Dec 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.14 | 0.32 | 0.33 | 0.60 | 1.09 |
| Quick Ratio | 0.88 | 0.27 | 0.33 | 0.60 | 0.76 |
| Cash Ratio | 0.05 | 0.14 | 0.05 | 0.11 | 0.33 |
| Solvency Ratio | -0.06 | -0.04 | 0.06 | -1.02 | -0.67 |
| Operating Cash Flow Ratio | -0.68 | -0.30 | -0.11 | -0.32 | -0.76 |
| Short-Term Operating Cash Flow Coverage | -17.76 | -0.43 | -0.21 | -1.01 | -1.48 |
| Net Current Asset Value | AU$ -10.68M | AU$ -7.88M | AU$ -4.78M | AU$ -6.47M | AU$ -3.17M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.58 | 0.35 | 0.24 | 0.16 | 0.14 |
| Debt-to-Equity Ratio | 5.41 | 0.74 | 0.46 | 0.35 | 0.22 |
| Debt-to-Capital Ratio | 0.84 | 0.42 | 0.31 | 0.26 | 0.18 |
| Long-Term Debt-to-Capital Ratio | 0.71 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 9.34 | 2.08 | 1.91 | 2.21 | 1.56 |
| Debt Service Coverage Ratio | -0.62 | -0.50 | 0.24 | -2.78 | -1.49 |
| Interest Coverage Ratio | -1.89 | -3.64 | -4.69 | -5.89 | -8.82 |
| Debt to Market Cap | 0.39 | 0.88 | 0.45 | 0.40 | 0.27 |
| Interest Debt Per Share | 0.03 | 0.02 | 0.01 | 0.02 | 0.03 |
| Net Debt to EBITDA | -5.44 | -2.96 | -2.37 | -0.22 | -0.25 |
| Profitability Margins | |||||
| Gross Profit Margin | 22.28% | 74.52% | 72.34% | -43.50% | 37.39% |
| EBIT Margin | -23.61% | -87.20% | -42.54% | -178.72% | -170.34% |
| EBITDA Margin | -19.79% | -38.09% | -19.73% | -152.63% | -147.22% |
| Operating Profit Margin | -25.31% | -74.77% | -36.32% | -112.26% | -128.25% |
| Pretax Profit Margin | -23.90% | -99.52% | -49.71% | -186.84% | -188.53% |
| Net Profit Margin | -13.61% | -57.97% | -16.40% | -186.84% | -162.03% |
| Continuous Operations Profit Margin | -13.61% | -57.97% | -16.40% | -186.84% | -168.11% |
| Net Income Per EBT | 56.94% | 58.25% | 32.99% | 100.00% | 85.94% |
| EBT Per EBIT | 94.44% | 133.11% | 136.87% | 166.44% | 147.01% |
| Return on Assets (ROA) | -7.16% | -14.58% | -7.57% | -64.82% | -29.16% |
| Return on Equity (ROE) | -66.86% | -30.35% | -14.47% | -143.35% | -45.52% |
| Return on Capital Employed (ROCE) | -17.94% | -38.92% | -30.04% | -63.53% | -30.11% |
| Return on Invested Capital (ROIC) | -9.80% | -22.46% | -6.95% | -52.81% | -22.28% |
| Return on Tangible Assets | -7.16% | -14.58% | -7.60% | -64.82% | -34.83% |
| Earnings Yield | -10.20% | -36.25% | -15.00% | -210.62% | -65.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.59 | 5.13 | 5.25 | 2.26 | 2.34 |
| Payables Turnover | 2.24 | 0.55 | 1.53 | 2.35 | 1.45 |
| Inventory Turnover | 6.06 | 2.70 | 0.00 | 0.00 | 1.42 |
| Fixed Asset Turnover | 0.77 | 0.30 | 0.55 | 0.46 | 0.31 |
| Asset Turnover | 0.53 | 0.25 | 0.46 | 0.35 | 0.18 |
| Working Capital Turnover Ratio | -2.62 | -0.93 | -1.79 | -5.71 | 2.39 |
| Cash Conversion Cycle | 38.27 | -456.15 | -169.06 | 6.41 | 160.78 |
| Days of Sales Outstanding | 140.94 | 71.17 | 69.47 | 161.40 | 156.00 |
| Days of Inventory Outstanding | 60.21 | 135.30 | 0.00 | 0.00 | 256.62 |
| Days of Payables Outstanding | 162.89 | 662.62 | 238.53 | 154.99 | 251.84 |
| Operating Cycle | 201.16 | 206.47 | 69.47 | 161.40 | 412.62 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.01 | -0.00 | -0.01 | -0.03 |
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.00 | -0.01 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | -18.42 | -34.85 | -7.03 | -4.86 | -7.26 |
| Capital Expenditure Coverage Ratio | -18.42 | -34.85 | -7.03 | -4.86 | -7.26 |
| Operating Cash Flow Coverage Ratio | -0.30 | -0.43 | -0.20 | -0.80 | -1.25 |
| Operating Cash Flow to Sales Ratio | -0.33 | -0.61 | -0.11 | -0.36 | -0.99 |
| Free Cash Flow Yield | -26.30% | -39.12% | -11.05% | -49.13% | -45.07% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -9.71 | -2.76 | -6.67 | -0.47 | -1.54 |
| Price-to-Sales (P/S) Ratio | 1.33 | 1.60 | 1.09 | 0.89 | 2.49 |
| Price-to-Book (P/B) Ratio | 6.55 | 0.84 | 0.96 | 0.68 | 0.70 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.80 | -2.56 | -9.05 | -2.04 | -2.22 |
| Price-to-Operating Cash Flow Ratio | -4.01 | -2.63 | -10.34 | -2.45 | -2.52 |
| Price-to-Earnings Growth (PEG) Ratio | 0.16 | -0.02 | 0.07 | -0.03 | 0.05 |
| Enterprise Value Multiple | -12.18 | -7.16 | -7.91 | -0.80 | -1.94 |
| Enterprise Value | 22.64M | 15.27M | 10.38M | 8.65M | 15.70M |
| EV to EBITDA | -12.18 | -7.16 | -7.91 | -0.80 | -1.94 |
| EV to Sales | 2.41 | 2.73 | 1.56 | 1.22 | 2.85 |
| EV to Free Cash Flow | -6.87 | -4.36 | -12.92 | -2.79 | -2.54 |
| EV to Operating Cash Flow | -7.24 | -4.49 | -14.76 | -3.36 | -2.89 |
| Tangible Book Value Per Share | 0.01 | 0.03 | 0.02 | 0.04 | 0.08 |
| Shareholders’ Equity Per Share | 0.01 | 0.03 | 0.02 | 0.04 | 0.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.43 | -0.42 | 0.67 | 0.00 | 0.14 |
| Revenue Per Share | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
| Net Income Per Share | -0.00 | -0.01 | -0.00 | -0.05 | -0.05 |
| Tax Burden | 0.57 | 0.58 | 0.33 | 1.00 | 0.86 |
| Interest Burden | 1.01 | 1.14 | 1.17 | 1.05 | 1.11 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.01 | 0.05 | 0.03 |
| SG&A to Revenue | 0.52 | 0.81 | 0.43 | 0.55 | 1.25 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 |
| Income Quality | 1.52 | 1.05 | 0.64 | 0.19 | 0.59 |
Currency in AUD
